4D Pharma (DDDD)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 94.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 174.00
  • 52 Week Low: 36.05
  • Currency: UK Pounds
  • Shares Issued: 180.30m
  • Volume: 673,939
  • Market Cap: 169.48m
  • Beta: 0.01

4D Pharma Overview

4D Pharma is in the pharma and biotech sector and is currently trading at 94.00p per share. In the last year 4D Pharma 's share price has ranged from 36.05p to 174.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -5694.3% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 319.8 n/a
Pr/Book 6.1  
Latest F'cast
Revenue 152.4% -100.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

4D Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 n/a (11.71) (15.21)p n/a n/a n/a n/a 0.0%
31-Dec-17 n/a (23.99) (26.08)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (28.44) (36.17)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.21 (29.43) (36.75)p n/a n/a n/a n/a 0.0%
31-Dec-20 0.53 (30.35) (22.80)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

4D Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 n/a (27.14) (12.61)p n/a n/a n/a n/a 0.0%
31-Dec-22 5.40 (26.99) (12.19)p n/a n/a n/a n/a 0.0%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

4D Pharma Company Announcements

Directors’ Subscription for new Ordinary S... 16-Apr-2021 07:00 RNS
Annual Financial Report 15-Apr-2021 17:00 RNS
Holding(s) in Company 12-Apr-2021 14:26 RNS

Latest 4D Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

4D Pharma Market Data

Currency UK Pounds
Share Price 94.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 174.00
52 Week Low 36.05
Volume 673,939
Shares Issued 180.30m
Market Cap 169.48m
Beta 0.01

4D Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.65% below the market average51.65% below the market average51.65% below the market average51.65% below the market average51.65% below the market average
19.23% below the sector average19.23% below the sector average19.23% below the sector average19.23% below the sector average19.23% below the sector average
Price Trend
29.94% below the market average29.94% below the market average29.94% below the market average29.94% below the market average29.94% below the market average
36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average
Income Not Available
Growth
20.88% above the market average20.88% above the market average20.88% above the market average20.88% above the market average20.88% above the market average
8.11% above the sector average8.11% above the sector average8.11% above the sector average8.11% above the sector average8.11% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

4D Pharma Dividends

No dividends found

Trades for 17-May-2021

Time Volume / Share Price
13:25 342 @ 94.00p
13:25 397 @ 94.00p
13:25 661 @ 94.00p
13:24 5,327 @ 93.85p
13:23 211 @ 93.70p

4D Pharma Key Personnel

CEO Duncan Joseph Peyton

Top of Page